LMAT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
LMAT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
LeMaitre Vascular has the Financial Strength Rank of 8. It shows strong financial strength and is unlikely to fall into distressed situations.
Good Sign:
LeMaitre Vascular Inc shows strong financial strength.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is rated on a scale of 1 to 10 and is based on these factors:
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.
LeMaitre Vascular's Interest Coverage for the quarter that ended in Dec. 2024 was 62.70. LeMaitre Vascular's debt to revenue ratio for the quarter that ended in Dec. 2024 was 0.83. As of today, LeMaitre Vascular's Altman Z-Score is 7.14.
For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's Financial Strength distribution charts can be found below:
* The bar in red indicates where LeMaitre Vascular's Financial Strength falls into.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
LeMaitre Vascular's Interest Expense for the months ended in Dec. 2024 was $-0.2 Mil. Its Operating Income for the months ended in Dec. 2024 was $12.9 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $183.0 Mil.
LeMaitre Vascular's Interest Coverage for the quarter that ended in Dec. 2024 is
Interest Coverage | = | -1 | * | Operating Income (Q: Dec. 2024 ) | / | Interest Expense (Q: Dec. 2024 ) |
= | -1 | * | 12.854 | / | -0.205 | |
= | 62.70 |
The higher the ratio, the stronger the company's financial strength is.
2. Debt to revenue ratio. The lower, the better.
LeMaitre Vascular's Debt to Revenue Ratio for the quarter that ended in Dec. 2024 is
Debt to Revenue Ratio | = | Total Debt (Q: Dec. 2024 ) | / | Revenue | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Revenue | |
= | (2.681 | + | 183.004) | / | 222.868 | |
= | 0.83 |
3. Altman Z-Score.
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
LeMaitre Vascular has a Z-score of 7.14, indicating it is in Safe Zones. This implies the Z-Score is strong.
Good Sign:
Altman Z-score of 7.14 is strong.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LeMaitre Vascular (NAS:LMAT) Financial Strength Explanation
The rank is rated on a scale of 1 to 10. A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.
LeMaitre Vascular has the Financial Strength Rank of 8. It shows strong financial strength and is unlikely to fall into distressed situations.
Thank you for viewing the detailed overview of LeMaitre Vascular's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.
Trent G Kamke | officer: Senior V. P., Operations | 61 WILLOWDEAN AVENUE, WEST ROXBURY MA 02132 |
Lawrence J Jasinski | director | SOTEIRA INC., 14 TECH CIRCLE, NATICK MA 01760 |
Bridget A Ross | director | C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747 |
Martha Shadan | director | 9201 W BROADWAY AVE, #650, MINNEAPOLIS MN 55445 |
David B Roberts | director, officer: CFO and Director | 55 BRADFORD STREET, NEEDHAM MA 02492 |
George W Lemaitre | director, 10 percent owner, officer: Chairman, President and CEO | 342 BUNKER HILL STREET, #2B, CHARLESTOWN MA 02129 |
John A Roush | director | C/O GSI GROUP INC., 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730-1409 |
Pellegrino Joseph P Jr | officer: Executive V.P. Finance | 68 BEACON STREET, BOSTON MA 02108 |
Michael H Thomas | director | P.O. BOX 2207, NOKOMIS FL 34274-2207 |
Peter R Gebauer | officer: President, International OP | AM WALDFELD 17, BAD SODEN 2M 65812 |
Michael T Wijas | officer: VP of Sales, The Americas | C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON MA 01803 |
Lemaitre Cornelia W | director, officer: V.P., Human Resources,Director | 8 SUNSET ROCK ROAD, ANDOVER MA 01810 |
Russell D Hays | director | C/O BIOSOURCE INTERNATIONAL INC, 542 FLYNN RD, CAMARILLO CA 93012 |
Robert V Linden | officer: VP, North American Sales | 236 WOODEN BRIDGE ROAD, HOLLAND PA 18966 |
Thorndike William N Jr | director | HOUSATONIC PARTNERS, 800 BOYLSTON STREET, SUITE 2220, BOSTON MA 02199 |
From GuruFocus
By GuruFocus News • 02-28-2025
By Marketwired • 02-27-2025
By GuruFocus News • 01-24-2025
By GuruFocus News • 11-01-2024
By GuruFocus News • 03-01-2025
By GuruFocus News • 02-28-2025
By Marketwired • 11-25-2024
By GuruFocus News • 03-03-2025
By Marketwired • 11-01-2024
By GlobeNewswire • 11-01-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.